These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 1648171

  • 1. Dissociation between early and late events in T cell activation mediated through CD28 surface molecule.
    Nunes J, Bagnasco M, Lopez M, Lipcey C, Mawas C, Olive D.
    Mol Immunol; 1991; 28(4-5):427-35. PubMed ID: 1648171
    [Abstract] [Full Text] [Related]

  • 2. Cholera toxin inhibits the increase in cytoplasmic free calcium induced via the CD2 pathway of human T-lymphocyte activation.
    Nunes J, Bagnasco M, Lopez M, Olive D, Mawas C.
    J Cell Biochem; 1989 Apr; 39(4):391-400. PubMed ID: 2542344
    [Abstract] [Full Text] [Related]

  • 3. Cholera toxin inhibits resting human T cell activation via a cAMP-independent pathway.
    Anderson DL, Tsoukas CD.
    J Immunol; 1989 Dec 01; 143(11):3647-52. PubMed ID: 2555413
    [Abstract] [Full Text] [Related]

  • 4. Cholera toxin modulates the T cell antigen receptor/CD3 complex but not the CD2 molecule and inhibits signaling via both receptor structures in the human T cell lymphoma Jurkat.
    Sommermeyer H, Schwinzer R, Kaever V, Wessel K, Schmidt RE, Behl B, Wonigeit K, Szamel M, Resch K.
    Eur J Immunol; 1989 Dec 01; 19(12):2387-90. PubMed ID: 2575034
    [Abstract] [Full Text] [Related]

  • 5. Cyclic AMP- and inositol phosphate-independent inhibition of Ca2+ influx by cholera toxin in CD3-stimulated Jurkat T cells. A study with a cholera toxin-resistant cell variant and the Ca2+ endoplasmic reticulum-ATPase inhibitor thapsigargin.
    Gouy H, Cefai D, Christensen SB, Debre P, Bismuth G.
    J Immunol; 1991 Aug 01; 147(3):757-66. PubMed ID: 1650386
    [Abstract] [Full Text] [Related]

  • 6. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies.
    Bjorndahl JM, Sung SS, Hansen JA, Fu SM.
    Eur J Immunol; 1989 May 01; 19(5):881-7. PubMed ID: 2544432
    [Abstract] [Full Text] [Related]

  • 7. Characterization of functional GTP binding proteins in Jurkat T cell mutants lacking either CD3-Ti or CD2 surface receptors.
    Moingeon P, Jin YJ, Stebbins CC, Lopez PA, Alcover A, Reinherz EL.
    Cell Immunol; 1990 Jul 01; 128(2):578-88. PubMed ID: 1972660
    [Abstract] [Full Text] [Related]

  • 8. Delineation of the mechanism of inhibition of human T cell activation by PGE2.
    Minakuchi R, Wacholtz MC, Davis LS, Lipsky PE.
    J Immunol; 1990 Oct 15; 145(8):2616-25. PubMed ID: 1976699
    [Abstract] [Full Text] [Related]

  • 9. Cholera toxin-mediated inhibition of signalling in Jurkat cells is followed by, but not due to a loss of T cell receptor complex.
    Sommermeyer H, Schwinzer R, Kaever V, Resch K.
    Immunobiology; 1991 Jun 15; 182(3-4):266-76. PubMed ID: 1655636
    [Abstract] [Full Text] [Related]

  • 10. T cell activation via the T cell receptor: a comparison between WT31 (defining alpha/beta TcR)-induced and anti-CD3-induced activation of human T lymphocytes.
    Gupta S, Shimizu M, Ohira K, Vayuvegula B.
    Cell Immunol; 1991 Jan 15; 132(1):26-44. PubMed ID: 1829655
    [Abstract] [Full Text] [Related]

  • 11. T cell receptor-independent CD2 signal transduction in FcR+ cells.
    Arulanandam AR, Koyasu S, Reinherz EL.
    J Exp Med; 1991 Apr 01; 173(4):859-68. PubMed ID: 1706751
    [Abstract] [Full Text] [Related]

  • 12. T cell receptor/CD3 and CD28 use distinct intracellular signaling pathways.
    Van Lier RA, Brouwer M, De Groot ED, Kramer I, Aarden LA, Verhoeven AJ.
    Eur J Immunol; 1991 Jul 01; 21(7):1775-8. PubMed ID: 1647959
    [Abstract] [Full Text] [Related]

  • 13. Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion.
    Ueda Y, Levine BL, Huang ML, Freeman GJ, Nadler LM, June CH, Ward SG.
    Int Immunol; 1995 Jun 01; 7(6):957-66. PubMed ID: 7577804
    [Abstract] [Full Text] [Related]

  • 14. Activation of CD3/TCR negative human thymocytes via CD28 molecule.
    Zocchi MR, Poggi A.
    Cell Immunol; 1991 Aug 01; 136(1):105-12. PubMed ID: 1647880
    [Abstract] [Full Text] [Related]

  • 15. Stimulation of MAP-2 kinase activity in T lymphocytes by anti-CD3 or anti-Ti monoclonal antibody is partially dependent on protein kinase C.
    Nel AE, Hanekom C, Rheeder A, Williams K, Pollack S, Katz R, Landreth GE.
    J Immunol; 1990 Apr 01; 144(7):2683-9. PubMed ID: 2156931
    [Abstract] [Full Text] [Related]

  • 16. Increased intracellular cyclic AMP inhibits inositol phospholipid hydrolysis induced by perturbation of the T cell receptor/CD3 complex but not by G-protein stimulation. Association with protein kinase A-mediated phosphorylation of phospholipase C-gamma 1.
    Alava MA, DeBell KE, Conti A, Hoffman T, Bonvini E.
    Biochem J; 1992 May 15; 284 ( Pt 1)(Pt 1):189-99. PubMed ID: 1318020
    [Abstract] [Full Text] [Related]

  • 17. CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma.
    Pohl C, Denfeld R, Renner C, Jung W, Bohlen H, Sahin U, Hombach A, van Lier R, Schwonzen M, Diehl V.
    Int J Cancer; 1993 Jul 09; 54(5):820-7. PubMed ID: 7686889
    [Abstract] [Full Text] [Related]

  • 18. FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes.
    Lin CS, Boltz RC, Siekierka JJ, Sigal NH.
    Cell Immunol; 1991 Apr 01; 133(2):269-84. PubMed ID: 1707760
    [Abstract] [Full Text] [Related]

  • 19. Signal transduction via CD4, CD8, and CD28 in mature and immature thymocytes. Implications for thymic selection.
    Turka LA, Linsley PS, Paine R, Schieven GL, Thompson GB, Ledbetter JA.
    J Immunol; 1991 Mar 01; 146(5):1428-36. PubMed ID: 1847160
    [Abstract] [Full Text] [Related]

  • 20. CD28 molecule as a receptor-like function for accessory signals in cell-mediated augmentation of IL-2 production.
    Kohno K, Shibata Y, Matsuo Y, Minowada J.
    Cell Immunol; 1990 Nov 01; 131(1):1-10. PubMed ID: 2171783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.